检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]复旦大学附属中山医院心脏内科,上海200032
出 处:《南京医科大学学报(自然科学版)》2016年第4期402-405,410,共5页Journal of Nanjing Medical University(Natural Sciences)
摘 要:慢性心衰患者心脏性猝死(sudden cardiac death,SCD)发生率高,植入性心律转复除颤器(implantable cardioverther defibrillator,ICD)是有效预防SCD的措施。多个学会已制定了ICD一级预防的适应证。国内ICD作为SCD一级预防的植入数量有限,原因复杂。应继续加强适应证的推广和执行力度,提高大众对SCD的了解,至少对更高危的SCD患者(一级预防适应证+晕厥或晕厥前兆或更低的左室射血分数或非持续性室性心动过速或频发室性早博)应使用ICD进行SCD的预防。Objective:Patients with chronic heart failure suffer high risk of sudden cardiac death(SCD),which has been proved to be efficiently prevented by implantable cardioverter defibrillator(ICD). There have been multiple guidelines proposing indications of ICD implantation for primary prevention of SCD. The number of ICD implantations in China is small and unsatisfying,for various reasons. Actions should be taken in propaganda so that this therapy is better known by the public,or at least patients with higher risk of SCD than currently indicated(ie,those with class I indications concurrently with syncop or presyncope,or with lower LVEF,or with unsustained ventricular tachycardia,or with frequent premature ventricular contractions) should receive ICD therapy without delay.
分 类 号:R541.6[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229